cached image

Joseph J. Schildkraut - Publications

Affiliations: 
Harvard Medical School, Boston, MA, United States 
Area:
Biological psychiatry, catecholamines
Website:
http://www.news.harvard.edu/gazette/2008/10.23/11-mm.html

82/223 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Mooney JJ, Samson JA, McHale NL, Pappalarado KM, Alpert JE, Schildkraut JJ. Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study. Journal of Psychiatric Research. 47: 706-11. PMID 23490066 DOI: 10.1016/J.Jpsychires.2013.02.005  0.328
2008 Mooney JJ, Samson JA, Hennen J, Pappalardo K, McHale N, Alpert J, Koutsos M, Schildkraut JJ. Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3). Journal of Psychiatric Research. 42: 605-11. PMID 17727882 DOI: 10.1016/J.Jpsychires.2007.07.009  0.354
2007 Schildkraut JJ, Cohn MB, Hawkins H. Then melancholy, now depression: a modern interpretation of Rembrandt's mental state in midlife. The Journal of Nervous and Mental Disease. 195: 3-9. PMID 17220733 DOI: 10.1097/01.Nmd.0000252263.74369.15  0.325
2004 Green AI, Chau DT, Keung WM, Dawson R, Mesholam RI, Schildkraut JJ. Clozapine reduces alcohol drinking in Syrian golden hamsters. Psychiatry Research. 128: 9-20. PMID 15450910 DOI: 10.1016/J.Psychres.2004.05.005  0.502
2004 Schildkraut JJ. Saint Jerome in a dark chamber: Rembrandt's metaphoric portrayal of the depressed mind. The American Journal of Psychiatry. 161: 26-7. PMID 14702245 DOI: 10.1176/Appi.Ajp.161.1.26  0.304
2003 Green A, Keung W, Chau D, Dawson R, Mesholam R, Schildkraut J. Clozapine limits alcohol drinking in hamsters: Implications for treatment of schizophrenia Schizophrenia Research. 60: 312. DOI: 10.1016/S0920-9964(03)80252-9  0.507
2002 Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, Schildkraut JJ, Green AI. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Research. 111: 11-20. PMID 12140115 DOI: 10.1016/S0165-1781(02)00123-3  0.526
1999 Green AI, Zimmet SV, Strous RD, Schildkraut JJ. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harvard Review of Psychiatry. 6: 287-96. PMID 10370435 DOI: 10.3109/10673229909017206  0.543
1999 Posener JA, Schatzberg AF, Williams GH, Samson JA, McHale NL, Bessette MP, Schildkraut JJ. Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man. Biological Psychiatry. 45: 222-8. PMID 9951570 DOI: 10.1016/S0006-3223(97)00550-7  0.322
1998 Mooney JJ, Samson JA, McHale NL, Colodzin R, Alpert J, Koutsos M, Schildkraut JJ. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). Biological Psychiatry. 43: 574-83. PMID 9564442 DOI: 10.1016/S0006-3223(97)00327-2  0.307
1997 Posener JA, Schildkraut JJ, Williams GH, Schatzberg AF. Cortisol feedback effects on plasma corticotropin levels in healthy subjects. Psychoneuroendocrinology. 22: 169-76. PMID 9203227 DOI: 10.1016/S0306-4530(96)00046-7  0.328
1997 Stone WS, Seidman LJ, Kalinowski A, Shagrin B, Patel JK, Shafa R, Canuso C, Schildkraut JJ, Green AI. Effects of clozapine on cognitive functions in treatment-refractory schizophrenia Schizophrenia Research. 24: 188-189. DOI: 10.1016/S0920-9964(97)82539-X  0.502
1996 Vasile RG, Schwartz RB, Garada B, Holman BL, Alpert M, Davidson PB, Schildkraut JJ. Focal cerebral perfusion defects demonstrated by 99mTc-hexamethylpropyleneamine oxime SPECT in elderly depressed patients. Psychiatry Research. 67: 59-70. PMID 8797243 DOI: 10.1016/0925-4927(96)02689-3  0.341
1996 Posener JA, Schildkraut JJ, Samson JA, Schatzberg AF. Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology. 21: 33-8. PMID 8778902 DOI: 10.1016/0306-4530(95)00033-X  0.337
1995 Green AI, Schildkraut JJ. Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients. Harvard Review of Psychiatry. 3: 1-9. PMID 9384923 DOI: 10.3109/10673229509017159  0.547
1995 Samson JA, Gurrera RJ, Nisenson L, Schildkraut JJ. Platelet monoamine oxidase activity and deficit syndrome schizophrenia. Psychiatry Research. 56: 25-31. PMID 7792339 DOI: 10.1016/0165-1781(94)02555-W  0.321
1995 Schildkraut JJ, Kopin IJ, Schanberg SM, Durell J. Norepinephrine metabolism and psychoactive drugs in the endogenous depressions. 1968. Pharmacopsychiatry. 28: 24-37. PMID 7480108 DOI: 10.1055/S-2007-979616  0.573
1995 Schildkraut JJ, Hirshfeld AJ. Mind and Mood in Modern Art I: Miró and “Melancolie” Creativity Research Journal. 8: 139-156. DOI: 10.1207/S15326934Crj0802_3  0.3
1995 Posener JA, Schildkraut JJ, Williams GH, Gleason RE, Salomon MS, Schatzberg AF. Acute and delayed effects of adrenocorticotropic hormone on dopamine activity in man Depression. 2: 292-296. DOI: 10.1002/Depr.3050020603  0.354
1994 Schildkraut JJ, Hirshfeld AJ, Murphy JM. Mind and mood in modern art, II: Depressive disorders, spirituality, and early deaths in the abstract expressionist artists of the New York School. The American Journal of Psychiatry. 151: 482-8. PMID 8147444 DOI: 10.1176/Ajp.151.4.482  0.307
1994 Samson JA, Mirin SM, Griffin M, Borrelli D, Schildkraut JJ. Urinary MHPG and clinical symptoms in patients with unipolar depression. Psychiatry Research. 51: 157-65. PMID 8022950 DOI: 10.1016/0165-1781(94)90035-3  0.344
1994 Posener JA, Schildkraut JJ, Williams GH, Gleason RE, Salomon MS, Mecheri G, Schatzberg AF. Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man. Biological Psychiatry. 36: 616-21. PMID 7833428 DOI: 10.1016/0006-3223(94)90074-4  0.314
1993 Green AI, Alam MY, Sobieraj JT, Pappalardo KM, Waternaux C, Salzman C, Schatzberg AF, Schildkraut JJ. Clozapine response and plasma catecholamines and their metabolites. Psychiatry Research. 46: 139-49. PMID 8483973 DOI: 10.1016/0165-1781(93)90016-A  0.554
1993 Green AI, Alam MY, Boshes RA, Waternaux C, Pappalardo KM, Fitzgibbon ME, Tsuang MT, Schildkraut JJ. Haloperidol response and plasma catecholamines and their metabolites. Schizophrenia Research. 10: 33-7. PMID 8369230 DOI: 10.1016/0920-9964(93)90074-S  0.57
1993 Rothschild AJ, Samson JA, Bond TC, Luciana MM, Schildkraut JJ, Schatzberg AF. Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression. Biological Psychiatry. 34: 392-400. PMID 8218607 DOI: 10.1016/0006-3223(93)90184-F  0.348
1992 Samson JA, Mirin SM, Hauser ST, Fenton BT, Schildkraut JJ. Learned helplessness and urinary MHPG levels in unipolar depression. The American Journal of Psychiatry. 149: 806-9. PMID 1590498 DOI: 10.1176/Ajp.149.6.806  0.353
1992 Schatzberg AF, Bowden CL, Rosenbaum AH, Samson JA, Dessain E, Schildkraut JJ. EFFECTS OF FLUOXETINE AND DESIPRAMINE ON URINARY CATECHOLAMINE AND METABOLITE EXCRETION IN MAJOR DEPRESSION Clinical Neuropharmacology. 15: 415B. DOI: 10.1097/00002826-199202001-00807  0.351
1992 bowden c, schatzberg a, rosenbaum a, contreras s, schildkraut j, dessain e. Effects Of Fluoxetine & Desipramine On Platelet Imipramine Binding In Major Depression Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00637  0.323
1991 Mooney JJ, Schatzberg AF, Cole JO, Samson JA, Waternaux C, Gerson B, Pappalardo KM, Schildkraut JJ. Urinary 3-methoxy-4-hydroxyphenylglycol and the: Depression-type Score as Predictors of Differential Journal of Clinical Psychopharmacology. 11: 339-343. DOI: 10.1097/00004714-199112000-00002  0.332
1989 Schatzberg AF, Samson JA, Bloomingdale KL, Orsulak PJ, Gerson B, Kizuka PP, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders. Archives of General Psychiatry. 46: 260-8. PMID 2783211 DOI: 10.1001/Archpsyc.1989.01810030066009  0.358
1988 Mooney JJ, Schatzberg AF, Cole JO, Kizuka PP, Salomon M, Lerbinger J, Pappalardo KM, Gerson B, Schildkraut JJ. Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase. Biological Psychiatry. 23: 543-59. PMID 2833319 DOI: 10.1016/0006-3223(88)90002-9  0.333
1987 Schatzberg AF, Rothschild AJ, Langlais PJ, Lerbinger JE, Schildkraut JJ, Cole JO. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms. Psychiatry Research. 20: 155-64. PMID 3575560 DOI: 10.1016/0165-1781(87)90007-2  0.379
1986 Bloomingdale KL, Vasile RG, Gudeman JE, Gerson B, Schildkraut JJ. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression. Biological Psychiatry. 21: 390-3. PMID 3955113 DOI: 10.1016/0006-3223(86)90167-8  0.312
1985 Schatzberg AF, Rothschild AJ, Gerson B, Lerbinger JE, Schildkraut JJ. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity. The British Journal of Psychiatry : the Journal of Mental Science. 146: 633-7. PMID 4016477 DOI: 10.1192/Bjp.146.6.633  0.34
1985 Biederman J, Herzog DB, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF, Harmatz JS, Tondorf R, Orsulak PJ, Schildkraut JJ. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology. 5: 10-6. PMID 3973067 DOI: 10.1097/00004714-198502000-00003  0.337
1985 Mooney JJ, Schatzberg AF, Cole JO, Kizuka PP, Schildkraut JJ. Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: preliminary data. Journal of Psychiatric Research. 19: 65-75. PMID 2985777 DOI: 10.1016/0022-3956(85)90069-X  0.364
1984 Biederman J, Herzog DB, Rivinus TM, Ferber RA, Harper GP, Orsulak PJ, Harmatz JS, Schildkraut JJ. Urinary mhpg in anorexia nervosa patients with and without a concomitant major depressive disorder. Journal of Psychiatric Research. 18: 149-60. PMID 6747913 DOI: 10.1016/0022-3956(84)90006-2  0.364
1984 Biederman J, Rivinus TM, Herzog DB, Ferber RA, Harper GP, Orsulak PJ, Harmatz JS, Schildkraut JJ. Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder. The American Journal of Psychiatry. 141: 1244-7. PMID 6486260 DOI: 10.1176/Ajp.141.10.1244  0.368
1984 Sheehan DV, Coleman JH, Greenblatt DJ, Jones KJ, Levine PH, Orsulak PJ, Peterson M, Schildkraut JJ, Uzogara E, Watkins D. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. Journal of Clinical Psychopharmacology. 4: 66-75. PMID 6142907 DOI: 10.1097/00004714-198404020-00002  0.323
1983 Schatzberg AF, Orsulak PJ, Rothschild AJ, Salomon MS, Lerbinger J, Kizuka PP, Cole JO, Schildkraut JJ. Platelet MAO activity and the dexamethasone suppression test in depressed patients. The American Journal of Psychiatry. 140: 1231-3. PMID 6614239 DOI: 10.1176/Ajp.140.9.1231  0.35
1981 Mooney JJ, Chao FC, Orsulak PJ, Adler SA, Schildkraut JJ. Platelet monoamine oxidase activity in psychiatric disorders: the application of a technique for the isolation of free platelet mitochondria from relatively small blood samples. Journal of Psychiatric Research. 16: 163-71. PMID 7346628 DOI: 10.1016/0022-3956(81)90002-9  0.504
1981 Cassens G, Kuruc A, Roffman M, Orsulak PJ, Schildkraut JJ. Alterations in brain norepinephrine metabolism and behavior induced by environmental stimuli previously paired with inescapable shock. Behavioural Brain Research. 2: 387-407. PMID 7225224 DOI: 10.1016/0166-4328(81)90020-6  0.317
1981 Schatzberg AF, Rosenbaum AH, Orsulak PJ, Rohde WA, Maruta T, Kruger ER, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline. Psychopharmacology. 75: 34-8. PMID 6795656 DOI: 10.1007/Bf00433498  0.356
1981 Cassens G, Actor C, Kling M, Schildkraut JJ. Amphetamine withdrawal: effects on threshold of intracranial reinforcement. Psychopharmacology. 73: 318-22. PMID 6789351 DOI: 10.1007/Bf00426458  0.311
1980 Cassens G, Roffman M, Kuruc A, Orsulak PJ, Schildkraut JJ. Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock. Science (New York, N.Y.). 209: 1138-40. PMID 7403874 DOI: 10.1126/Science.7403874  0.302
1980 Adler SA, Gottesman II, Orsulak PJ, Kizuka PP, Schildkraut JJ. Platelet MAO activity: relationships to clinical and psychometric variables. Schizophrenia Bulletin. 6: 226-31. PMID 7375854 DOI: 10.1093/Schbul/6.2.226  0.612
1980 Schildkraut JJ, Orsulak PJ, Schatzberg AF, Herzog JM. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders. Schizophrenia Bulletin. 6: 220-5. PMID 7375853 DOI: 10.1093/Schbul/6.2.220  0.36
1980 Reigle TG, Orsulak PJ, Avni J, Platz PA, Schildkraut JJ. The effects of tranylcypromine isomers on norepinephrine-H3 metabolism in rat brain. Psychopharmacology. 69: 193-9. PMID 6779313 DOI: 10.1007/Bf00427649  0.326
1979 Roffman M, Reigle T, Orsulak P, Cassens G, Schildkraut JJ. Further studies of the effects of morphine on the levels of MHPG-SO4 in rat brain. Neuropharmacology. 18: 483-7. PMID 460544 DOI: 10.1016/0028-3908(79)90074-1  0.327
1978 Schildkraut JJ, Orsulak PJ, LaBrie RA, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA. Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites. Archives of General Psychiatry. 35: 1436-9. PMID 727879 DOI: 10.1001/Archpsyc.1978.01770360040004  0.341
1978 Schildkraut JJ, Orsulak PJ, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA, LaBrie RA. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions. Archives of General Psychiatry. 35: 1427-33. PMID 727878 DOI: 10.1001/Archpsyc.1978.01770360031003  0.372
1978 Roffman M, Cassens G, Schildkraut JJ. Effects of the d- and l-isomers of amphetamine on the levels of 3-methoxy-4-hydroxyphenylglycol sulfate in whole rat brain and rat brain regions. Biochemical Pharmacology. 27: 1774-7. PMID 708459 DOI: 10.1016/0006-2952(78)90556-7  0.302
1978 Meyer RE, Schildkraut JJ, Mirin SM, Orsulak PJ, Randall M, McDougle M, Platz PA, Grab E, Babor T. Opiates, catecholamines, behavior, and mood. Psychopharmacology. 56: 327-33. PMID 418442 DOI: 10.1007/Bf00432857  0.374
1976 Schildkraut JJ, Herzog JM, Orsulak PJ, Edelman SE, Shein HM, Frazier SH. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. The American Journal of Psychiatry. 133: 438-40. PMID 1267046 DOI: 10.1176/Ajp.133.4.438  0.3
1974 Schildkraut JJ. The effects of lithium on norepinephrine turnover and metabolism: basic and clinical studies. The Journal of Nervous and Mental Disease. 158: 348-60. PMID 4823935 DOI: 10.1097/00005053-197405000-00006  0.357
1974 Reigle TG, Avni J, Platz PA, Schildkraut JJ, Plotnikoff NP. Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone. Psychopharmacologia. 37: 1-6. PMID 4213267 DOI: 10.1007/Bf00426676  0.38
1973 Schildkraut JJ. Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. The American Journal of Psychiatry. 130: 695-9. PMID 4701961 DOI: 10.1176/Ajp.130.6.695  0.373
1973 Schildkraut JJ, Keeler BA, Papousek M, Hartmann E. MHPG excretion in depressive disorders: relation to clinical subtypes and desynchronized sleep. Science (New York, N.Y.). 181: 762-4. PMID 4353428 DOI: 10.1126/Science.181.4101.762  0.351
1973 Roffler-Tarlov S, Schildkraut JJ, Draskoczy PR. Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain. Biochemical Pharmacology. 22: 2923-6. PMID 4148604 DOI: 10.1016/0006-2952(73)90161-5  0.304
1972 Schildkraut JJ, Draskoczy PR, Gershon ES, Reich P, Grab EL. Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline. Journal of Psychiatric Research. 9: 173-85. PMID 5083173 DOI: 10.1016/0022-3956(72)90019-2  0.421
1972 Schildkraut JJ, Hartmann E. Turnover and metabolism of norepinephrine in rat brain after 72 hours on a D-deprivation island. Psychopharmacologia. 27: 17-27. PMID 5081367 DOI: 10.1007/Bf00421953  0.36
1971 Schildkraut JJ, Draskoczy PR, Lo PS. Norepinephrine pools in rat brain: differences in turnover rates and pathways of metabolism. Science (New York, N.Y.). 172: 587-8. PMID 5555080 DOI: 10.1126/Science.172.3983.587  0.343
1971 Schildkraut JJ, Winokur A, Draskóczy PR, Hensle JH. Changes in norepinephrine turnover in rat brain during chronic administration of imipramine and protriptyline: a possible explanation for the delay in onset of clinical antidepressant effects. The American Journal of Psychiatry. 127: 1032-9. PMID 5541194 DOI: 10.1176/Ajp.127.8.1032  0.354
1971 Schildkraut JJ, Efron DH. The effects of delta-9-tetrahydrocannabinol on the metabolism of norepinephrine in rat brain. Psychopharmacologia. 20: 191-6. PMID 5090538 DOI: 10.1007/Bf00404373  0.374
1970 Schildkraut JJ, Winokur A, Applegate CW. Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine. Science (New York, N.Y.). 168: 867-9. PMID 5444064 DOI: 10.1126/Science.168.3933.867  0.346
1970 Greenspan K, Schildkraut JJ, Gordon EK, Baer L, Aronoff MS, Durell J. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate. Journal of Psychiatric Research. 7: 171-83. PMID 5440858 DOI: 10.1016/0022-3956(70)90004-X  0.308
1970 Schildkraut JJ. Tranylcypromine: effects on norepinephrine metabolism in rat brain. The American Journal of Psychiatry. 126: 925-31. PMID 5409564 DOI: 10.1176/Ajp.126.7.925  0.406
1969 Schildkraut JJ, Schanberg SM, Breese GR, Kopin IJ. Effects of psychoactive drugs on the metabolism of intracisternally administered serotonin in rat brain. Biochemical Pharmacology. 18: 1971-8. PMID 5811629 DOI: 10.1016/0006-2952(69)90293-7  0.603
1969 Schildkraut JJ, Dodge GA, Logue MA. Effects of tricyclic antidepressants on the uptake and mabolism of intracisternally administered norepinephrine-H3 in rat brain. Journal of Psychiatric Research. 7: 29-34. PMID 5352848 DOI: 10.1016/0022-3956(69)90009-0  0.358
1969 Schildkraut JJ, Logue MA, Dodge GA. The effects of lthium salts on the turnover and metabolism of norepinephrine in rat brain. Psychopharmacologia. 14: 135-41. PMID 5350622 DOI: 10.1007/Bf00403686  0.359
1969 Greenspan K, Schildkraut JJ, Gordon EK, Levy B, Durell J. Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients. Archives of General Psychiatry. 21: 710-6. PMID 4901154 DOI: 10.1001/Archpsyc.1969.01740240070009  0.389
1969 Schildkraut JJ, Schanberg SM, Kopin IJ, Durell J. Affective disorders and norepinephrine pharmacology. International Psychiatry Clinics. 6: 83-141. PMID 4897536  0.487
1968 Schanberg SM, Schildkraut JJ, KrÄ­vánek J, Kopin IJ. Effect of cortical spreading depression on norepinephrine-H3 metabolism in brain stem. Experientia. 24: 909-10. PMID 5709032 DOI: 10.1007/Bf02138647  0.587
1968 Schanberg SM, Schildkraut JJ, Breese GR, Kopin IJ. Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochemical Pharmacology. 17: 247-54. PMID 5647052 DOI: 10.1016/0006-2952(68)90330-4  0.588
1967 Schanberg SM, Schildkraut JJ, Kopin IJ. The effects of pentobarbital on the fate of intracisternally administered norepinephrine-H3. The Journal of Pharmacology and Experimental Therapeutics. 157: 311-8. PMID 6039823  0.499
1967 Schanberg SM, Schildkraut JJ, Kopin IJ. The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. Biochemical Pharmacology. 16: 393-9. PMID 6029920 DOI: 10.1016/0006-2952(67)90040-8  0.594
1967 Schildkraut JJ, Kety SS. Biogenic amines and emotion. Science (New York, N.Y.). 156: 21-37. PMID 5335690 DOI: 10.1126/Science.156.3771.21  0.579
1967 Schildkraut JJ, Schanberg SM, Breese GR, Kopin IJ. Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action. The American Journal of Psychiatry. 124: 600-8. PMID 4383104 DOI: 10.1176/Ajp.124.5.600  0.601
1966 Schildkraut JJ, Schanberg SM, Kopin IJ. The effects of lithium ion on H3-norepinephrine metabolism in brain. Life Sciences. 5: 1479-83. PMID 5969204 DOI: 10.1016/0024-3205(66)90221-9  0.519
1966 Schildkraut JJ, Green R, Gordon EK, Durell J. Normetanephrine excretion and affective state in depressed patients treated with imipramine. The American Journal of Psychiatry. 123: 690-700. PMID 5333088 DOI: 10.1176/Ajp.123.6.690  0.374
1964 SCHILDKRAUT JJ, KLERMAN GL, HAMMOND R, FRIEND DG. EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID (VMA) IN DEPRESSED PATIENTS TREATED WITH ANTIDEPRESSANT DRUGS. Journal of Psychiatric Research. 2: 257-66. PMID 14271965 DOI: 10.1016/0022-3956(64)90012-3  0.365
1963 KLERMAN GL, SCHILDKRAUT JJ, HASENBUSH LL, GREENBLATT M, FRIEND DG. CLINICAL EXPERIENCE WITH DIHYDROXYPHENYLALANINE (DOPA) IN DEPRESSION. Journal of Psychiatric Research. 1: 289-97. PMID 14101009 DOI: 10.1016/0022-3956(63)90004-9  0.38
Low-probability matches (unlikely to be authored by this person)
1974 Schildkraut JJ. Catecholamine metabolism and affective disorders: Studies of MHPG excretion Biochemical Pharmacology. 23: 977-983. DOI: 10.1016/0006-2952(74)90172-5  0.299
1977 Roffman M, Cassens G, Schildkraut JJ. The effects of acute and chronic administration of morphine on norepinephrine turnover in rat brain regions. Biochemical Pharmacology. 26: 2355-8. PMID 597324 DOI: 10.1016/0006-2952(77)90440-3  0.293
1998 Posener JA, Schildkraut JJ, Williams GH, Schatzberg AF. Late feedback effects of hypothalamic-pituitary-adrenal axis hormones in healthy subjects. Psychoneuroendocrinology. 23: 371-83. PMID 9695137 DOI: 10.1016/S0306-4530(98)00006-7  0.291
1972 Stern WC, Hartmann EL, Draskoczy PR, Schildkraut JJ. Behavioral Effects of Centrally Administered 6-Hydroxydopamine Psychological Reports. 30: 815-820. DOI: 10.2466/Pr0.1972.30.3.815  0.288
2004 Schildkraut JJ, Mooney JJ. Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis. The American Journal of Psychiatry. 161: 909-11. PMID 15121658 DOI: 10.1176/Appi.Ajp.161.5.909  0.281
1963 SCHILDKRAUT JJ, KLERMAN GL, FRIEND DG, GREENBLATT M. Biochemical and pressor effects of oral D,L-dihydroxy-phenylalanine in patients pretreated with antidepressant drugs. Annals of the New York Academy of Sciences. 107: 1005-15. PMID 13991689 DOI: 10.1111/J.1749-6632.1963.Tb13344.X  0.277
1992 Vasile RG, Duffy FH, McAnulty G, Mooney JJ, Bloomingdale K, Schildkraut JJ. Abnormal flash visual evoked response in melancholia: a replication study. Biological Psychiatry. 31: 325-36. PMID 1558897 DOI: 10.1016/0006-3223(92)90226-P  0.277
1980 Schatzberg AF, Orsulak PJ, Rosenbaum AH, Kruger ER, Schildkraut JJ, Cole JO. Catecholamine measures for diagnosis and treatment of patients with depressive disorders. The Journal of Clinical Psychiatry. 41: 35-9. PMID 7440524  0.275
1979 Orsulak PJ, Schildkraut JJ. Guidelines for therapeutic monitoring of tricyclic antidepressant plasma levels. Therapeutic Drug Monitoring. 1: 199-208. PMID 555572 DOI: 10.1097/00007691-197901020-00002  0.275
1978 Orsulak PJ, Schildkraut JJ, Schatzberg AF, Herzog JM. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Biological Psychiatry. 13: 637-47. PMID 737252  0.273
1971 Hartmann E, Bridwell TJ, Schildkraut JJ. Alpha-methylparatyrosine and sleep in the rat. Psychopharmacologia. 21: 157-64. PMID 5570196 DOI: 10.1007/Bf00403630  0.272
1970 Schildkraut JJ. Neurochemical studies of the affective disorders: the pharmacological bridge. The American Journal of Psychiatry. 127: 358-60. PMID 5460154 DOI: 10.1176/Ajp.127.3.358  0.268
1972 Watson R, Hartmann E, Schildkraut JJ. Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. The American Journal of Psychiatry. 129: 263-9. PMID 4340897 DOI: 10.1176/Ajp.129.3.263  0.262
1965 Schildkraut JJ, Gordon EK, Durell J. Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine. Journal of Psychiatric Research. 3: 213-28. PMID 5866611  0.261
1987 Glassman AH, Arana GW, Baldessarini RJ, Brown WA, Carroll BJ, Davis JM, Greenblatt DJ, Klerman GL, Orsulak P, Schildkraut JJ, Shader RI. The dexamethasone suppression test: An overview of its current status in psychiatry American Journal of Psychiatry. 144: 1253-1262. PMID 3310667  0.259
1986 Biederman J, Baldessarini RJ, Harmatz JS, Rivinus TM, Arana GW, Herzog DB, Schildkraut JJ. Heterogeneity in anorexia nervosa. Biological Psychiatry. 21: 213-6. PMID 3004610 DOI: 10.1016/0006-3223(86)90149-6  0.258
1982 Schildkraut JJ. The biochemical discrimination of subtypes of depressive disorders: an outline of our studies on norepinephrine metabolism and psychoactive drugs in the endogenous depressions since 1967. Pharmacopsychiatria. 15: 121-7. PMID 7146090 DOI: 10.1055/s-2007-1019523  0.248
1985 Samson JA, Gudeman JE, Schatzberg AF, Kizuka PP, Orsulak PJ, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions. Journal of Psychiatric Research. 19: 547-55. PMID 4078757 DOI: 10.1016/0022-3956(85)90072-X  0.245
1981 Mooney JJ, Chao FC, Orsulak PJ, Schildkraut JJ. An improved method for the recovery of mitochondrial monoamine oxidase from human platelets using colchicine and nitrogen decompression. Biochemical Medicine. 26: 156-66. PMID 7317037 DOI: 10.1016/0006-2944(81)90042-9  0.244
1978 Schildkraut JJ, Orsulak PJ, Schatzberg AF, Cole JO, Gudeman JE, Rohde WA. Elevated platelet MAO activity in schizophrenia-related depressive disorders. The American Journal of Psychiatry. 135: 110-2. PMID 618506  0.244
1992 Anderson JL, Vasile RG, Mooney JJ, Bloomingdale KL, Samson JA, Schildkraut JJ. Changes in norepinephrine output following light therapy for fall/winter seasonal depression. Biological Psychiatry. 32: 700-4. PMID 1457625 DOI: 10.1016/0006-3223(92)90299-F  0.241
1971 Hartmann E, Chung R, Draskoczy PR, Schildkraut JJ. Effects of 6-hydroxydopamine on sleep in the rat. Nature. 233: 425-7. PMID 4940441 DOI: 10.1038/233425A0  0.238
1985 Mooney JJ, Cole JO, Schatzberg AF, Gerson B, Schildkraut JJ. Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam. The American Journal of Psychiatry. 142: 366-7. PMID 2857533  0.238
1992 Schildkraut JJ, Schatzberg AF, Samson JA, Rosenbaum A, Bowden CL. Norepinephrine output and metabolism in depressed patients during antidepressant treatments. Clinical Neuropharmacology. 15: 323A-324A. PMID 1498855  0.237
1969 Schildkraut JJ, Dodge GA, Logue MA. Preliminary findings on the effects of amitriptyline on norepinephrine-H3 metabolism in rat brain. Diseases of the Nervous System. 30: Suppl:44-6. PMID 5775312  0.233
1992 Rosenbaum AH, Schatzberg AF, Bowden CL, Samson JA, Schildkraut JJ. MHPG AS A PREDICTOR OF CLINICAL RESPONSE TO FLUOXETINE Clinical Neuropharmacology. 15: 209B. DOI: 10.1097/00002826-199202001-00403  0.232
1974 Schildkraut JJ. Proceedings: Norepinephrine metabolism in subtypes of depressive disorders. Psychopharmacology Bulletin. 10: 49-50. PMID 4431872  0.231
1982 Gudeman JE, Schatzberg AF, Samson JA, Orsulak PJ, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients. The American Journal of Psychiatry. 139: 630-3. PMID 7072851  0.23
1980 Rosenbaum AH, Schatzberg AF, Maruta T, Orsulak PJ, Cole JO, Grab EL, Schildkraut JJ. MHPG as a predictor of antidepressant response to imipramine and maprotiline. The American Journal of Psychiatry. 137: 1090-2. PMID 7425162  0.23
1974 Schildkraut JJ. Biochemical criteria for classifying depressive disorders and predicting responses to pharmacotherapy: preliminary findings from studies of norepinephrine metabolism. Contributions to biochemistry. Pharmakopsychiatrie, Neuro-Psychopharmakologie. 7: 98-107. PMID 4438430 DOI: 10.1055/s-0028-1094408  0.229
1982 Schatzberg AF, Orsulak PJ, Rosenbaum AH, Maruta T, Kruger ER, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions. The American Journal of Psychiatry. 139: 471-5. PMID 7065292  0.228
1980 Schatzberg AF, Orsulak PJ, Rosenbaum AH, Maruta T, Kruger ER, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders IV: Pretreatment urinary MHPG levels as predictors of antidepressant response to imipramine. Communications in Psychopharmacology. 4: 441-5. PMID 7333096  0.227
1976 Schildkraut JJ, Roffman M, Orsulak PJ, Schatzberg AF, Kling MA, Reigle TG. Effects of short-and long-term administration of tricyclic antidepressants and lithium on norepinephrine turnover in brain. Pharmakopsychiatrie, Neuro-Psychopharmakologie. 9: 193-202. PMID 981331 DOI: 10.1055/s-0028-1094493  0.224
1983 Rosenbaum AH, Maruta T, Schatzberg AF, Orsulak PJ, Jiang NS, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions. The American Journal of Psychiatry. 140: 314-8. PMID 6829802  0.224
1981 Schatzberg AF, Rosenbaum AH, Orsulak PJ, Rohde WA, Maruta T, Kruger ER, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders - III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline Psychopharmacology. 75: 34-38. DOI: 10.1007/BF00433498  0.221
1974 Reigle TG, Platz PA, Avni J, Schildkraut JJ. Influence of tranylcypromine isomers on the disposition and metabolism of norepinephrine H3 in rat brain Federation Proceedings. 33: No. 238.  0.219
1976 Roffman M, Reigle TG, Orsulak PJ, Schildkraut JJ. Properties of catechol-O-methyl transferase in soluble and particulate preparations from rat red blood cells. Biochemical Pharmacology. 25: 208-9. PMID 4077 DOI: 10.1016/0006-2952(76)90294-X  0.217
1981 Schildkraut JJ, Orsulak PJ, Schatzberg AF, Cole JO, Rosenbaum AH. Possible pathophysiological mechanisms in subtypes of unipolar depressive disorders based on differences in urinary MHPG levels [proceedings]. Psychopharmacology Bulletin. 17: 90-91. PMID 7232668  0.215
2000 SCHILDKRAUT JJ. Beyond Reason: Art and Psychosis: Works From the Prinzhorn Collection American Journal of Psychiatry. 157: 2068-a-2070. DOI: 10.1176/Appi.Ajp.157.12.2068-A  0.207
1991 Mooney JJ, Schatzberg AF, Cole JO, Samson JA, Waternaux C, Gerson B, Pappalardo KM, Schildkraut JJ. Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants. Journal of Clinical Psychopharmacology. 11: 339-43. PMID 1770151  0.207
1989 Vasile RG, Duffy FH, McAnulty G, Bear D, Mooney JJ, Bloomingdale K, Serchuck LK, Schildkraut JJ. Abnormal visual evoked response in melancholia. Biological Psychiatry. 25: 785-8. PMID 2923938 DOI: 10.1016/0006-3223(89)90250-3  0.204
1990 Schildkraut JJ, Mooney JJ, Jacobs SC, Friedman R, McHale N, Benson H. Enhanced signal transduction by adenylate cyclase following elicitation of the relaxation response: Preliminary findings Journal of Psychiatric Research. 24: 55-56. DOI: 10.1016/0022-3956(90)90084-4  0.203
1975 Roffman M, Orsulak PJ, Schildkraut JJ. Further studies on the effects of drugs of addiction on the turnover of norepinephrine (NE) in rat brain Federation Proceedings. 34: No. 3217.  0.201
1973 Hartmann E, Schildkraut JJ. Desynchronized sleep and MHPG excretion: an inverse correlation. Brain Research. 61: 412-6. PMID 4773170 DOI: 10.1016/0006-8993(73)90548-9  0.197
1976 Roffman M, Cassens G, Kling M, Schildkraut JJ. Effects of drugs of addiction on the levels of MHPG SO4 in whole rat brain and various brain regions Federation Proceedings. 35: No.1460.  0.191
1973 Schildkraut JJ, Keeler BA, Grab EL, Kantrowich J, Hartmann E. M.H.P.G. excretion and clinical classification in depressive disorders. Lancet. 1: 1251-2. PMID 4122600  0.191
1979 Cassens G, Kuruc A, Orsulak PJ, Schildkraut JJ. Amphetamine withdrawal: effects on brain levels of MHPG-SO4 in the rat. Communications in Psychopharmacology. 3: 217-23. PMID 575083  0.19
1988 Minden SL, Orav J, Schildkraut JJ. Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology. 38: 1631-4. PMID 2843795  0.19
1974 Schildkraut JJ. The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment. Psychopharmacology Bulletin. 10: 5-25. PMID 4590871  0.189
1977 Roffman M, Kling MA, Cassens G, Orsulak PJ, Reigle TG, Schildkraut JJ. The effects of acute and chronic administration of tricyclic antidepressants on MHPG-SO4 in rat brain. Communications in Psychopharmacology. 1: 195-206. PMID 606473  0.185
1975 Schildkraut JJ. Psychopharmacology of biogenic amines in depressions. Psychopharmacology Bulletin. 11: 58-9. PMID 1135382  0.184
1991 HIRSHFELD A, SCHILDKRAUT JJ. Psychoanalytic Perspectives on Art, vol. 3 American Journal of Psychiatry. 148: 1738-a-1739. DOI: 10.1176/Ajp.148.12.1738-A  0.178
1989 SCHILDKRAUT JJ. Psychoanalytic Perspectives on Art, vol.2 American Journal of Psychiatry. 146: 674-674. DOI: 10.1176/Ajp.146.5.674  0.178
1975 Schildkraut JJ, Meyer RE, Orsulak PJ, Mirin SM, Roffman M, Platz PA, Grab E, Randall ME, McDougle M. The effects of heroin on catecholamine metabolism in man. National Institute On Drug Abuse Research Monograph Series. 137-45. PMID 1233382  0.178
1990 Hirshfeld A, Schildkraut JJ. Pictures at an Exhibition: Selected Essays on Art and Art Therapy. The American Journal of Psychiatry. 147: 1685-1686. PMID 26772682 DOI: 10.1176/Ajp.147.12.1685  0.177
1995 SCHILDKRAUT JJ, HIRSHFELD AJ, MURPHY JM. Dr. Schildkraut and Colleagues Reply American Journal of Psychiatry. 152: 816-b-817. DOI: 10.1176/Ajp.152.5.816-B  0.175
1995 HIRSHFELD AJ, SCHILDKRAUT JJ. Madness and Art: The Life and Works of Adolf Wölfli American Journal of Psychiatry. 152: 1094-a-1095. DOI: 10.1176/Ajp.152.7.1094-A  0.174
1975 Roffman M, Reigle T, Orsulak P, Schildkraut JJ. The effects of acute and chronic morphine administration on the levels of 3-methoxy-4-hydroxphenylglycol sulfate in rat brain. Research Communications in Chemical Pathology and Pharmacology. 10: 403-17. PMID 1135507  0.174
1971 Schildkraut JJ, Watson R, Draskoczy PR. Amphetamine withdrawal: depression and M.H.P.G. excretion. Lancet. 2: 485-6. PMID 4105344  0.171
1998 SCHILDKRAUT JJ. Adolf Wölfli: Draftsman, Writer, Poet, Composer American Journal of Psychiatry. 155: 1787a-1788. DOI: 10.1176/Ajp.155.12.1787A  0.171
1971 Schildkraut JJ. Noradrenergic activity during the transition from depression to mania. Lancet. 1: 653. PMID 4101263  0.171
1984 Schildkraut JJ, Sandler M. Editorial: Software survey section Journal of Psychiatric Research. 18: I-III. DOI: 10.1016/0022-3956(90)90029-P  0.165
1975 Avni J, Gerson S, Draskoczy PR, Schildkraut JJ. Norepinephrine content of various rat organs after chronic administration of desmethylimipramine. Archives Internationales De Pharmacodynamie Et De Thã©Rapie. 218: 106-9. PMID 1212010  0.162
1977 Schildkraut JJ, Meyer RE, Orsulak PJ, Mirin SM, Roffman M, Platz PA, Grab E, Randall ME, McDougle M. Catecholamine metabolism during heroin use. The American Journal of Psychiatry. 134: 534-7. PMID 848581  0.157
1972 Schildkraut J. Norepinephrine metabolism in affective disorders Comprehensive Psychiatry. 13: 88. DOI: 10.1016/0010-440X(72)90047-8  0.154
1973 Schildkraut JJ. Catecholamine metabolism and affective disorders Life Sciences. 13: cxl-cxlii. DOI: 10.1016/0024-3205(73)90388-3  0.152
1975 Schildkraut JJ. Norepinephrine metabolism after short- and long-term administration of tricyclic antidepressant drugs and electroconvulsive shock. Advances in Biochemical Psychopharmacology. 13: 137-53. PMID 1155232  0.141
1983 Orsulak PJ, Kizuka P, Grab E, Schildkraut JJ. Determination of urinary normetanephrine and metanephrine by radial-compression liquid chromatography and electrochemical detection. Clinical Chemistry. 29: 305-9. PMID 6821934  0.138
1987 Vasile RG, Samson JA, Bemporad J, Bloomingdale KL, Creasey D, Fenton BT, Gudeman JE, Schildkraut JJ. A biopsychosocial approach to treating patients with affective disorders. The American Journal of Psychiatry. 144: 341-4. PMID 2881492  0.129
1966 Schildkraut JJ. Antidepressant drugs. Science (New York, N.Y.). 154: 1058-61. PMID 17752811 DOI: 10.1126/science.154.3752.1058  0.123
2007 Schildkraut JJ, Cohn MB, Hawkins H. Then melancholy, now depression: A modern interpretation of Rembrandt's mental state in midlife (Journal of Nervous and Mental Disease (2006) 195, 1, (3-9)) Journal of Nervous and Mental Disease. 195: 1033. DOI: 10.1097/NMD.0613e3181614c  0.122
1995 Neylan TC, Schildkraut JJ. Pathophysiology of affective disorders: Joseph J. Schildkraut's catecholamine hypothesis Journal of Neuropsychiatry and Clinical Neurosciences. 7: 523-533.  0.122
1972 Schildkraut JJ. Neuropharmacological studies of mood disorders. Proceedings of the Annual Meeting of the American Psychopathological Association. 60: 65-92. PMID 4551137  0.122
1995 Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. 1965. The Journal of Neuropsychiatry and Clinical Neurosciences. 7: 524-33; discussion 5. PMID 8555758  0.12
1967 Schildkraut JJ. The catecholamine hypothesis of affective disorders. A review of supporting evidence. International Journal of Psychiatry. 4: 203-17. PMID 4863731  0.12
1965 Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. The American Journal of Psychiatry. 122: 509-22. PMID 5319766  0.12
1975 Schildkraut JJ. Catecholamines in affective disorders. Psychopharmacology Bulletin. 11: 35. PMID 1153657  0.118
1974 Schildkraut JJ. Biogenic amines and affective disorders. Annual Review of Medicine. 25: 333-48. PMID 4368455 DOI: 10.1146/annurev.me.25.020174.002001  0.111
1973 Schildkraut JJ. Neuropharmacology of the affective disorders. Annual Review of Pharmacology. 13: 427-54. PMID 4197470 DOI: 10.1146/annurev.pa.13.040173.002235  0.108
1969 Schildkraut JJ. Neuropsychopharmacology and the affective disorders (second of three parts). The New England Journal of Medicine. 281: 248-55. PMID 4892998 DOI: 10.1056/NEJM196907312810506  0.107
1969 Schildkraut JJ. Neuropsychopharmacology and the affective disorders. (Third of three parts) The New England Journal of Medicine. 281: 302-8 concl. PMID 4894568 DOI: 10.1056/NEJM196908072810606  0.107
1969 Schildkraut JJ. Neuropsychopharmacology and the affective disorders. (First of three parts). The New England Journal of Medicine. 281: 197-201 contd. PMID 4892804 DOI: 10.1056/NEJM196907242810405  0.107
1979 Appelbaum PS, Vasile RG, Orsulak PJ, Schildkraut JJ. Clinical utility of tricyclic antidepressant blood levels: a case report. The American Journal of Psychiatry. 136: 339-41. PMID 570360  0.105
2012 Liu Y, Murphy SK, Murtha AP, Fuemmeler BF, Schildkraut J, Huang Z, Overcash F, Kurtzberg J, Jirtle R, Iversen ES, Forman MR, Hoyo C. Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elements. Epigenetics. 7: 735-46. PMID 22677950 DOI: 10.4161/Epi.20734  0.101
1982 Mooney JJ, Horne WC, Handin RI, Schildkraut JJ, Alexander RW. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes. Molecular Pharmacology. 21: 600-8. PMID 6287197  0.091
1974 Roffman M, Riegle T, Orsulak P, Schildkraut JJ. Proceedings: Comparative properties of soluble and particulate catechol-O-methyl transferase from rat red blood cell: preliminary observations. Psychopharmacology Bulletin. 10: 43. PMID 4419340  0.074
1974 Roffman M, Reigle TG, Orsulak PJ, Schildkraut JJ. Comparative properties of soluble and particulate catechol-O-methyl transferases from rat red blood cells: preliminary observations. Advances in Biochemical Psychopharmacology. 12: 189-94. PMID 4417821  0.073
2014 Block MS, Charbonneau B, Vierkant RA, Fogarty Z, Bamlet WR, Pharoah PD, Rossing MA, Cramer D, Pearce CL, Schildkraut J, Menon U, Kjaer SK, et al. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1421-7. PMID 24740199 DOI: 10.1158/1055-9965.Epi-13-0962  0.062
2011 Shete S, Lau CC, Houlston RS, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, Yang P, Vick NA, et al. Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Research. 71: 7568-75. PMID 22037877 DOI: 10.1158/0008-5472.Can-11-0013  0.057
2013 Sadetzki S, Bruchim R, Oberman B, Armstrong GN, Lau CC, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut J, Johansen C, Houlston RS, Shete S, Amos CI, Bernstein JL, Olson SH, et al. Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. European Journal of Cancer (Oxford, England : 1990). 49: 1335-45. PMID 23290425 DOI: 10.1016/J.Ejca.2012.11.009  0.055
2014 Lee JH, Cragun D, Thompson Z, Coppola D, Nicosia SV, Akbari M, Zhang S, McLaughlin J, Narod S, Schildkraut J, Sellers TA, Pal T. Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer. Genetic Testing and Molecular Biomarkers. 18: 229-35. PMID 24592941 DOI: 10.1089/Gtmb.2013.0393  0.055
2014 Hedditch EL, Gao B, Russell AJ, Lu Y, Emmanuel C, Beesley J, Johnatty SE, Chen X, Harnett P, George J, Williams RT, Flemming C, Lambrechts D, Despierre E, ... ... Schildkraut J, et al. ABCA transporter gene expression and poor outcome in epithelial ovarian cancer. Journal of the National Cancer Institute. 106. PMID 24957074 DOI: 10.1093/Jnci/Dju149  0.053
2014 Hoyo C, Daltveit AK, Iversen E, Benjamin-Neelon SE, Fuemmeler B, Schildkraut J, Murtha AP, Overcash F, Vidal AC, Wang F, Huang Z, Kurtzberg J, Seewaldt V, Forman M, Jirtle RL, et al. Erythrocyte folate concentrations, CpG methylation at genomically imprinted domains, and birth weight in a multiethnic newborn cohort. Epigenetics : Official Journal of the Dna Methylation Society. 9: 1120-30. PMID 24874916 DOI: 10.4161/Epi.29332  0.052
2014 Brenner DR, Scherer D, Muir K, Schildkraut J, Boffetta P, Spitz MR, Le Marchand L, Chan AT, Goode EL, Ulrich CM, Hung RJ. A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1729-51. PMID 24962838 DOI: 10.1158/1055-9965.Epi-14-0064  0.051
2015 Jalali A, Amirian ES, Bainbridge MN, Armstrong GN, Liu Y, Tsavachidis S, Jhangiani SN, Plon SE, Lau CC, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut J, Ali-Osman F, Sadetzki S, et al. Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the Gliogene Consortium. Scientific Reports. 5: 8278. PMID 25652157 DOI: 10.1038/Srep08278  0.048
2006 Lancaster JM, Sayer RA, Blanchette C, Calingaert B, Konidari I, Gray J, Schildkraut J, Schomberg DW, Marks JR, Berchuck A. High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels International Journal of Gynecological Cancer. 16: 1529-1535. PMID 16884361 DOI: 10.1111/J.1525-1438.2006.00623.X  0.048
2015 Bainbridge MN, Armstrong GN, Gramatges MM, Bertuch AA, Jhangiani SN, Doddapaneni H, Lewis L, Tombrello J, Tsavachidis S, Liu Y, Jalali A, Plon SE, Lau CC, Parsons DW, Claus EB, ... ... Schildkraut J, et al. Germline mutations in shelterin complex genes are associated with familial glioma. Journal of the National Cancer Institute. 107: 384. PMID 25482530 DOI: 10.1093/Jnci/Dju384  0.046
2013 Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Risch HA, Yu H, Doherty JA, Chang-Claude J, ... ... Schildkraut J, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocrine-Related Cancer. 20: 251-62. PMID 23404857 DOI: 10.1530/Erc-12-0395  0.045
1972 Crowley TJ, Kripke DF, Halberg F, Pegram GV, Schildkraut JJ. Circadian rhythms ofMacaca mulatta: Sleep, EEG, body and eye movement, and temperature Primates. 13: 149-167. DOI: 10.1007/Bf01840877  0.043
2013 Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, ... ... Schildkraut J, et al. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prevention Research (Philadelphia, Pa.). 6: 811-21. PMID 23761272 DOI: 10.1158/1940-6207.Capr-13-0037  0.041
2012 Liu Y, Melin BS, Rajaraman P, Wang Z, Linet M, Shete S, Amos CI, Lau CC, Scheurer ME, Tsavachidis S, Armstrong GN, Houlston RS, Hosking FJ, Claus EB, Barnholtz-Sloan J, ... ... Schildkraut J, et al. Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Human Genetics. 131: 1507-17. PMID 22688887 DOI: 10.1007/S00439-012-1187-X  0.041
2013 Wiemels JL, Bracci PM, Wrensch M, Schildkraut J, Bondy M, Pfefferle J, Zhou M, Sison J, Calvocoressi L, Claus EB. Assessment of autoantibodies to meningioma in a population-based study. American Journal of Epidemiology. 177: 75-83. PMID 23221727 DOI: 10.1093/Aje/Kws221  0.041
1995 Rothenberg A, Milman DH, Corwin D, Schildkraut JJ, Hirshfeld AJ, Murphy JM. Creativity and mental illness [11 American Journal of Psychiatry. 152: 815-817. PMID 7726334  0.036
2013 Pooley KA, Bojesen SE, Weischer M, Nielsen SF, Thompson D, Amin Al Olama A, Michailidou K, Tyrer JP, Benlloch S, Brown J, Audley T, Luben R, Khaw KT, Neal DE, Hamdy FC, ... ... Schildkraut J, et al. A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Human Molecular Genetics. 22: 5056-64. PMID 23900074 DOI: 10.1093/Hmg/Ddt355  0.036
2006 Matthews AG, Betensky RA, Anton-Culver H, Bowen D, Griffin C, Isaacs C, Kasten C, Mineau G, Nayfield S, Schildkraut J, Strong L, Weber B, Finkelstein DM. Analysis of co-aggregation of cancer based on registry data. Community Genetics. 9: 87-92. PMID 16612058 DOI: 10.1159/000091485  0.036
2012 Sun X, Vengoechea J, Elston R, Chen Y, Amos CI, Armstrong G, Bernstein JL, Claus E, Davis F, Houlston RS, Il'yasova D, Jenkins RB, Johansen C, Lai R, Lau CC, ... ... Schildkraut J, et al. A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 2242-51. PMID 22962404 DOI: 10.1158/1055-9965.Epi-12-0703  0.036
2011 Il'yasova D, Siamakpour-Reihani S, Akushevich I, Akushevich L, Spector N, Schildkraut J. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma? Breast Cancer Research and Treatment. 130: 691-7. PMID 21850396 DOI: 10.1007/s10549-011-1719-4  0.035
2012 Fridley BL, Jenkins GD, Tsai YY, Song H, Bolton KL, Fenstermacher D, Tyrer J, Ramus SJ, Cunningham JM, Vierkant RA, Chen Z, Chen YA, Iversen E, Menon U, Gentry-Maharaj A, ... Schildkraut J, et al. Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 529-36. PMID 22302016 DOI: 10.1158/1055-9965.Epi-11-0741  0.035
2011 Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, Gammon MD, Douglas Thompson W, Bernstein JL. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Research and Treatment. 130: 587-97. PMID 21667121 DOI: 10.1007/s10549-011-1616-x  0.034
2010 Robertson LB, Armstrong GN, Olver BD, Lloyd AL, Shete S, Lau C, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Yang P, et al. Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation. Familial Cancer. 9: 413-21. PMID 20455025 DOI: 10.1007/S10689-010-9346-5  0.034
2013 Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, ... ... Schildkraut J, et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes & Control : Ccc. 24: 989-1004. PMID 23456270 DOI: 10.1007/S10552-013-0174-4  0.032
2014 Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, ... ... Schildkraut J, et al. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research. 74: 852-61. PMID 24272484 DOI: 10.1158/0008-5472.Can-13-1051  0.031
1971 Schildkraut JJ. Biochemistry of Mental Disorders—Technical Report Series No. 427 Psychosomatic Medicine. 33: 384. DOI: 10.1097/00006842-197107000-00012  0.03
2008 Pearce CL, Wu AH, Gayther SA, Bale AE, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, ... ... Schildkraut J, et al. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. British Journal of Cancer. 98: 282-8. PMID 18219286 DOI: 10.1038/Sj.Bjc.6604170  0.029
2015 Vidal AC, Semenova V, Darrah T, Vengosh A, Huang Z, King K, Nye MD, Fry R, Skaar D, Maguire R, Murtha A, Schildkraut J, Murphy S, Hoyo C. Maternal cadmium, iron and zinc levels, DNA methylation and birth weight. Bmc Pharmacology & Toxicology. 16: 20. PMID 26173596 DOI: 10.1186/S40360-015-0020-2  0.028
2007 Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, ... ... Schildkraut J, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Research. 67: 3027-35. PMID 17409409 DOI: 10.1158/0008-5472.Can-06-3261  0.027
2012 Perkins E, Murphy SK, Murtha AP, Schildkraut J, Jirtle RL, Demark-Wahnefried W, Forman MR, Kurtzberg J, Overcash F, Huang Z, Hoyo C. Insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children. The Journal of Pediatrics. 161: 31-9. PMID 22341586 DOI: 10.1016/J.Jpeds.2012.01.015  0.026
2014 Andersson U, Wibom C, Cederquist K, Aradottir S, Borg A, Armstrong GN, Shete S, Lau CC, Bainbridge MN, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Houlston RS, Schildkraut J, et al. Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Neuro-Oncology. 16: 1333-40. PMID 24723567 DOI: 10.1093/Neuonc/Nou052  0.026
2010 Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature Genetics. 42: 874-9. PMID 20852632 DOI: 10.1038/Ng.668  0.024
2009 Permuth-Wey J, Boulware D, Valkov N, Livingston S, Nicosia S, Lee JH, Sutphen R, Schildkraut J, Narod S, Parker A, Coppola D, Sellers T, Pal T. Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer Cancer Epidemiology Biomarkers and Prevention. 18: 28-34. PMID 19124477 DOI: 10.1158/1055-9965.Epi-08-0713  0.024
2005 Kelemen L, James M, Spurdle A, Campbell I, Chang-Claude J, Peel D, Anton-Culver H, Berchuck A, Schildkraut J, Whittemore A, McGurie V, DiCioccio RA, Duffy D, Chenevix-Trench G. BRAF polymorphisms and the risk of ovarian cancer of low malignant potential. Gynecologic Oncology. 97: 807-12. PMID 15904951 DOI: 10.1016/J.Ygyno.2005.03.007  0.023
2012 Finkelman BS, Rubinstein WS, Friedman S, Friebel TM, Dubitsky S, Schonberger NS, Shoretz R, Singer CF, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder C, Garber JE, ... Schildkraut J, et al. Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1321-8. PMID 22430266 DOI: 10.1200/Jco.2011.37.8133  0.023
2010 Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Schildkraut J, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 42: 880-4. PMID 20852633 DOI: 10.1038/Ng.666  0.022
2014 Segev Y, Pal T, Rosen B, McLaughlin JR, Sellers TA, Risch HA, Zhang S, Sun P, Narod SA, Schildkraut J. Risk factors for ovarian cancers with and without microsatellite instability. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 24: 664-9. PMID 24755492 DOI: 10.1097/IGC.0000000000000134  0.022
1978 Schildkraut JJ. Chemotherapy in Psychiatry Psychosomatic Medicine. 40: 268-269. DOI: 10.1097/00006842-197805000-00010  0.02
2012 Pal T, Akbari MR, Sun P, Lee JH, Fulp J, Thompson Z, Coppola D, Nicosia S, Sellers TA, McLaughlin J, Risch HA, Rosen B, Shaw P, Schildkraut J, Narod SA. Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer. British Journal of Cancer. 107: 1783-90. PMID 23047549 DOI: 10.1038/bjc.2012.452  0.019
2013 Segev Y, Pal T, Rosen B, McLaughlin JR, Sellers TA, Risch HA, Zhang S, Ping S, Narod SA, Schildkraut J. Risk factors for ovarian cancers with and without microsatellite instability. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 1010-5. PMID 23748177 DOI: 10.1097/Igc.0B013E31829A5527  0.019
2013 Schildkraut J. An inmate's right to die: legal and ethical considerations in death row volunteering Criminal Justice Studies. 26: 139-150. DOI: 10.1080/1478601X.2012.720575  0.019
2014 Schildkraut J, Hernandez TC. Laws That Bit The Bullet: A Review of Legislative Responses to School Shootings American Journal of Criminal Justice. 39: 358-374. DOI: 10.1007/s12103-013-9214-6  0.017
2015 Jaymi Elsass H, Schildkraut J, Stafford MC. Studying School Shootings: Challenges and Considerations for Research American Journal of Criminal Justice. DOI: 10.1007/s12103-015-9311-9  0.017
2014 Schildkraut J, Stafford MC. Researching Professionals or Professional Researchers? A Comparison of Professional Doctorate and PhD Programs in Criminology & Criminal Justice American Journal of Criminal Justice. 1-16. DOI: 10.1007/s12103-014-9240-z  0.016
2014 Schildkraut J, Mustaine EE. Movin', But Not Up To The East Side: Foreclosures and Social Disorganization in Orange County, Florida Housing Studies. 29: 177-197. DOI: 10.1080/02673037.2014.848263  0.012
2009 Cunningham JM, Vierkant RA, Sellers TA, Phelan C, Rider DN, Liebow M, Schildkraut J, Berchuck A, Couch FJ, Wang X, Fridley BL, Gentry-Maharaj A, Menon U, Hogdall E, et al. Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. British Journal of Cancer. 101: 1461-8. PMID 19738611 DOI: 10.1038/Sj.Bjc.6605284  0.012
2015 Segev Y, Zhang S, Akbari MR, Sun P, Sellers TA, McLaughlin J, Risch HA, Rosen B, Shaw P, Schildkraut J, Narod SA, Pal T. Survival in women with ovarian cancer with and without microsatellite instability European Journal of Gynaecological Oncology. 36: 681-684. DOI: 10.12892/ejgo2728.2015  0.01
2015 Schildkraut J, Elsass HJ, Stafford MC. Could it happen here? Moral panic, school shootings, and fear of crime among college students Crime, Law and Social Change. 63: 91-110. DOI: 10.1007/s10611-015-9552-z  0.01
2014 Schildkraut J, Muschert GW. Media Salience and the Framing of Mass Murder in Schools: A Comparison of the Columbine and Sandy Hook Massacres Homicide Studies. 18: 23-43. DOI: 10.1177/1088767913511458  0.01
2013 Wentzensen N, Trabert B, Schildkraut J. Ovarian Cancer Women and Health. 1135-1145. DOI: 10.1016/B978-0-12-384978-6.00075-3  0.01
2012 Coppola D, Nicosia SV, Doty A, Sellers TA, Lee JH, Fulp J, Thompson Z, Galeb S, McLaughlin J, Narod SA, Schildkraut J, Pal T. Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer. Anticancer Research. 32: 4963-9. PMID 23155266  0.01
2012 Schildkraut J, Donley AM. Murder in Black: A Media Distortion Analysis of Homicides in Baltimore in 2010 Homicide Studies. 16: 175-196. DOI: 10.1177/1088767912438712  0.01
2010 Domchek SM, Friebel TM, Singer CF, Gareth Evans D, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van T'veer L, Tung N, Weitzel JN, Couch FJ, ... ... Schildkraut J, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality Jama - Journal of the American Medical Association. 304: 967-975. PMID 20810374 DOI: 10.1001/Jama.2010.1237  0.01
1979 Schildkraut JJ, Feigelson EB, Johansen KH, Willingham TA. Book Reviews Academic Psychiatry. 3: 113-117. DOI: 10.1007/BF03399730  0.01
Hide low-probability matches.